# Comparison of 2 Days Versus 5 Days of Octreotide After Endoscopic Therapy in Preventing Early Esophageal Varices Rebleed : A Randomized Controlled Study

> **NCT05199038** · PHASE4 · UNKNOWN · sponsor: **Tanta University** · enrollment: 184 (estimated)

## Conditions studied

- Esophageal Varices

## Interventions

- **DRUG:** Octreotide

## Key facts

- **NCT ID:** NCT05199038
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06
- **Primary completion:** 2023-06
- **Final completion:** 2023-11
- **Target enrollment:** 184 (ESTIMATED)
- **Last updated:** 2022-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05199038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05199038, "Comparison of 2 Days Versus 5 Days of Octreotide After Endoscopic Therapy in Preventing Early Esophageal Varices Rebleed : A Randomized Controlled Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05199038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*